QI
RMD icon

Qtron Investments’s ResMed RMD Stock Holding History

Qtron Investments’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$741K Buy
3,302
+2
+0.1% +$498 0.1% 257
2025
Q4 		$795K Hold
3,300
– – 0.1% 230
2025
Q3 		$903K Buy
3,300
+418
+15% +$114K 0.11% 212
2025
Q2 		$744K Hold
2,882
– – 0.1% 255
2025
Q1 		$645K Buy
+2,882
New +$673K 0.1% 261
2024
Q3 		– Sell
-2,292
Closed -$439K – 473
2024
Q2 		$439K Sell
2,292
-472
-17% -$95.8K 0.06% 335
2024
Q1 		$547K Sell
2,764
-476
-15% -$87.2K 0.08% 326
2023
Q4 		$557K Buy
+3,240
New +$498K 0.09% 302
2023
Q1 		– Sell
-1,365
Closed -$284K – 449
2022
Q4 		$284K Hold
1,365
– – 0.06% 351
2022
Q3 		$298K Buy
+1,365
New +$311K 0.07% 333

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Qtron Investments's RMD Position: Q1 2026 in Review

Qtron Investments increased its ResMed (RMD) stake by 0.06% in Q1 2026, buying an estimated $498 and bringing the position to 3,302 shares worth $741K. The position accounts for 0.1% of the portfolio, ranked #257.

Qtron Investments first reported a position in RMD in Q3 2022 and has held it in 10 quarters since. The position peaked at $903K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Qtron Investments held 3,302 shares of ResMed worth $741K as of Q1 2026.
  • Qtron Investments bought 2 ResMed shares in Q1 2026, an estimated $498.
  • ResMed made up 0.1% of Qtron Investments's portfolio in Q1 2026, its #257 holding.
  • Qtron Investments first reported a position in ResMed in Q3 2022 and has held it in 10 quarters since.
  • Qtron Investments's ResMed position peaked at $903K in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Qtron Investments's 13F filing for Q1 2026, filed 15 May 2026.